InsidersTradesSigma
Discover the full directors' dealings record of 엔지켐생명과학, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 엔지켐생명과학 has published 7 reports. Market capitalisation: €76.2bn. The latest transaction was disclosed on 8 May 2026 — Purchase. Among the most active insiders: 브리짓라이프사이언스. The full history is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations